High Tower Advisors, LLC Ampio Pharmaceuticals, Inc. Call Options Transaction History

High Tower Advisors, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2022 May 12, 2022	SELL	$0.42 - $0.62 $30,122 - $44,466	-71,720 Reduced 99.61%	280 $3,000
Q2 2021 Aug 06, 2021	BUY	$1.56 - $1.98 $112,320 - $142,560	72,000 New	72,000 $45,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.